NCT04029181 2024-05-03
ImmunoPET With an Anti-CD8 Imaging Agent
University Medical Center Groningen
Phase 1/2 Unknown
Clinical Trials
90 trialsNCT04243720 2024-03-12
IRIS
University Health Network, Toronto
Unknown
NCT06231628 2024-01-30
Imaging Guided Cementoplasty for Pelvic Bone Metastasis
Assiut University
Phase NA Unknown
NCT06186427 2024-01-22
68Ga-GPFAPI
Guangdong Provincial People's Hospital
Phase NA Unknown
NCT06196151 2024-01-09
The Effect of Antenatal Education on Fear of Birth, Physiological Ability to Give Birth and Traumatic Birth Perception
Pamukkale University
Phase NA Unknown
NCT05237349 2024-01-05
Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT04987112 2023-12-22
Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors
CanWell Pharma Inc.
Phase 1 Unknown
NCT06087770 2023-12-18
Clinical Study of SM3321 With Solid Tumors
Beijing StarMab Biomed Technology Ltd
Phase 1 Unknown
NCT05289076 2023-12-01
CRLM-Z
University Hospital, Linkoeping
Phase 1/2 Unknown
NCT05245136 2023-11-18
ALPS
University Hospital Augsburg
Unknown
NCT06117371 2023-11-07
Study of BEBT-607 Tablets in The Treatment of Advanced or Metastatic Solid Tumors With KRAS G12C Mutation
BeBetter Med Inc
Phase 1 Unknown
NCT05324046 2023-08-18
Comparison Between LDCT With DL Recontruction and Standard Dose CT
Seoul National University Hospital
Unknown
NCT04033354 2023-08-08
A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC
Shanghai Henlius Biotech
Phase 3 Unknown
NCT03284502 2023-08-01
HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors
Hanmi Pharmaceutical Company Limited
Phase 1 Unknown
NCT05268666 2023-06-15
A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors
Jubilant Therapeutics Inc.
Phase 1/2 Unknown
NCT05904457 2023-06-15
BRISK
Asan Medical Center
Phase 2 Unknown
NCT05769075 2023-04-24
A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 Alterations
TYK Medicines, Inc
Phase 1 Unknown
NCT05232409 2023-04-20
Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer
Valley Health System
Phase 1 Unknown
NCT05755009 2023-03-07
ST-CR01
Jiangxi Provincial Cancer Hospital
Phase NA Unknown
NCT05263986 2023-02-27
The Clinical Trial to Evaluate the Pharmacokinetics and Safety of MRTX849 in Patients With Advanced Solid Tumors
Zai Lab (Hong Kong), Ltd.
Phase 1 Unknown
NCT04614740 2022-12-13
The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid Tumors
Jiangsu vcare pharmaceutical technology co., LTD
Phase 1/2 Unknown
NCT03774979 2022-11-08
SHR-1701 in Subjects With Metastatic or Locally Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
NCT03491631 2022-11-04
Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
NCT05530200 2022-09-07
PRaG Regimens Rechallenge for Patients With Resistance to PD1/PD-L1 Inhibitors in Refractory Advanced Solid Tumors.
Second Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT05435768 2022-08-18
PRaG 2X
Second Affiliated Hospital of Soochow University
Unknown
NCT05438342 2022-06-29
An Expanded Clinical Study of Triple Therapy for Refractory Solid Tumors That Failed First-line Treatment for Recurrence and Metastasis
Shanghai Pudong Hospital
Phase NA Unknown
NCT02593578 2022-06-15
Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.
Samsung Medical Center
Unknown
NCT02646228 2022-06-15
Establishment of Patient Derived Cancer Cell Models to Interrogate Novel Molecular Targets in Metastatic Cancer
Samsung Medical Center
Unknown
NCT05385081 2022-05-23
PRECODE
Odense University Hospital
Phase NA Unknown
NCT03646071 2022-04-13
A Study of RX108 in Patients With Locally Advanced or Metastatic Solid Tumors
NeuPharma, Inc.
Phase 1 Unknown
NCT05189717 2022-04-05
A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of Adults
Shandong Suncadia Medicine Co., Ltd.
Phase 1 Unknown
NCT05288608 2022-04-04
FAST-METS
Amsterdam UMC, location VUmc
Unknown
NCT03835949 2022-04-01
Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer
Tracon Pharmaceuticals Inc.
Phase 1 Unknown
NCT05302843 2022-03-31
A Phase 1 Study of BPI-28592 in Subjects With Advanced Solid Tumors
Betta Pharmaceuticals Co., Ltd.
Phase 1 Unknown
NCT05238818 2022-02-14
Single Arm Phase I Trail of Autologous Tumor Infiltrating Lymphocyte Injection (GT202) in the Treatment of Metastatic or Recurrent Gynecological Tumors
Obstetrics & Gynecology Hospital of Fudan University
Phase 1 Unknown
NCT05200273 2022-01-20
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114
Akeso
Phase 1 Unknown
NCT02773524 2022-01-13
INTEGRATEIIa
Australasian Gastro-Intestinal Trials Group
Phase 3 Unknown
NCT04671654 2021-12-21
SEEDLING
University Hospital Heidelberg
Unknown
NCT04990739 2021-12-17
Study of MTB-9655, an Inhibitor of ACSS2, in Patients With Advanced Solid Tumors
MetaboMed Inc
Phase 1 Unknown
NCT03710265 2021-11-22
SHR-1701 in Metastatic or Locally Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
NCT04859777 2021-09-16
A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors
Monopteros Therapeutics Inc.
Phase 1 Unknown
NCT04989192 2021-08-18
Dose Efficiency of Modern CT Scanners in Oncologic Scans
University Hospital Augsburg
Phase NA Unknown
NCT04921553 2021-08-02
TRacKING
Centre Leon Berard
Unknown
NCT03205735 2021-07-02
DPD DIG
Centre Antoine Lacassagne
Unknown
NCT03669601 2021-06-04
ATRiUM
Cambridge University Hospitals NHS Foundation Trust
Phase 1 Unknown
NCT03873103 2021-06-01
The Belgian Molecular Profiling Program of Metastatic Cancer for Clinical Decision and Treatment Assignment
The Belgian Society of Medical Oncology
Unknown
NCT04641676 2021-05-28
A Study to Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center
The Belgian Society of Medical Oncology
Phase NA Unknown
NCT04793061 2021-03-11
FLUIDO
Elisabethinen Hospital
Unknown
NCT02795650 2021-02-26
AVATAR
Hospital Universitario de Fuenlabrada
Phase 2 Unknown
NCT04761744 2021-02-21
A Phase II Study of Nivolumab in Patients With Genetic Alterations in DNA Damage Repair and Response Who Progressed After Standard Treatment for Metastatic Solid Cancers
Korean Cancer Study Group
Phase 2 Unknown